title
PROPOSED RESOLUTION
HONORING DR. WILLIS L. LONZER, III AS THE NEW GENERAL PRESIDENT OF ALPHA PHI ALPHA FRATERNITY, INCORPORATED
WHEREAS, Dr. Willis L. Lonzer, III was born on March 7, 1963 in Richmond, Virginia. Dr. Lonzer, III attended Delaware State University where he earned a Bachelors of Science Degree in Chemistry and a Doctor of Philosophy Degree in Biochemistry from the University of Akron; and
WHEREAS, Dr. Willis L. Lonzer, III was awarded a National Institutes of Health sponsored Postdoctoral Fellowship in Physiology and Biophysics at Case Western Reserve University School of Medicine. While at Case Western Reserve University, Dr. Lonzer, III's research involved understanding the structure and function of proteins and enzymes while providing insight into the pathophysiology of diseases such as Cystic Fibrosis, Alzheimer's Disease, and more; and
WHEREAS, after a brief tenure in academia, Dr. Willis L. Lonzer, III has over 20 years of global corporate experience in research and development with companies such as AstraZeneca, Johnson & Johnson, Abbott, AbbVie, and Takeda/Shire Pharmaceuticals. Dr. Lonzer, III currently serves as the Regional Medical Director at Horizon Therapeutics, a global biopharmaceutical company; and
WHEREAS, Dr. Willis L. Lonzer, III is a member of Alpha Phi Alpha Fraternity, Incorporated where he was initiated at Delaware State University through the Gamma Sigma Chapter on November 15, 1986. Alpha Phi Alpha Fraternity, Incorporated is the first intercollegiate Greek-letter fraternity for African-American Men founded on December 4, 1906 at Cornell University in Ithaca, New York. The fraternity has played a fundamental role in the positive development of the character and education of more than 200,000 men; and
WHEREAS, Dr. Willis L. Lonzer, III's fraternal service has included serving as a Chapter President at the college and alumni levels-Area Director, District Director of Ohio, and as the Midwestern Regional Vice Presid...
Click here for full text